This study is about testing a new way to find pancreatic cancer early using a blood test called the Enzeavour assay in Japan. Pancreatic cancer is a type of cancer that starts in the pancreas, an organ that helps digest food and control blood sugar. The Enzeavour assay checks for specific enzymes and biomarkers in the blood to get an Enzeavour Score. If this score is higher than 0.369, it might mean there's a chance of pancreatic cancer, and the person will need more tests to be sure. The goal is to see how well this test works in finding cancer in people who don't have any symptoms.

Key Points:

• The study involves approximately 10,000 adults in Japan.
• Participants with a high score will undergo further testing.
• The study lasts for 12 months, tracking cancer detection rates.

To join, you must be an adult in Japan having regular health checkups without any symptoms of pancreatic cancer. You cannot participate if you have had pancreatic cancer before or cannot have follow-up tests.